Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

139 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
How to measure the immunosuppressive activity of MDSC: assays, problems and potential solutions.
Bruger AM, Dorhoi A, Esendagli G, Barczyk-Kahlert K, van der Bruggen P, Lipoldova M, Perecko T, Santibanez J, Saraiva M, Van Ginderachter JA, Brandau S. Bruger AM, et al. Among authors: van ginderachter ja, van der bruggen p. Cancer Immunol Immunother. 2019 Apr;68(4):631-644. doi: 10.1007/s00262-018-2170-8. Epub 2018 May 21. Cancer Immunol Immunother. 2019. PMID: 29785656 Free PMC article. Review.
Protocol to assess the suppression of T-cell proliferation by human MDSC.
Bruger AM, Vanhaver C, Bruderek K, Amodio G, Tavukçuoğlu E, Esendagli G, Gregori S, Brandau S, van der Bruggen P. Bruger AM, et al. Among authors: van der bruggen p. Methods Enzymol. 2020;632:155-192. doi: 10.1016/bs.mie.2019.05.046. Epub 2019 Jul 8. Methods Enzymol. 2020. PMID: 32000895
Identification of an Immature Subset of PMN-MDSC Correlated to Response to Checkpoint Inhibitor Therapy in Patients with Metastatic Melanoma.
Gondois-Rey F, Paul M, Alcaraz F, Bourass S, Monnier J, Malissen N, Grob JJ, Bruger AM, Van Der Bruggen P, Gaudy-Marqueste C, Olive D. Gondois-Rey F, et al. Among authors: van der bruggen p. Cancers (Basel). 2021 Mar 17;13(6):1362. doi: 10.3390/cancers13061362. Cancers (Basel). 2021. PMID: 33802925 Free PMC article.
HELIOS-expressing human CD8 T cells exhibit limited effector functions.
Neyens D, Hirsch T, Abdel Aziz Issa Abdel Hadi A, Dauguet N, Vanhaver C, Bayard A, Wildmann C, Luyckx M, Squifflet JL, D'Hondt Q, Duhamel C, Huaux A, Montiel V, Dechamps M, van der Bruggen P. Neyens D, et al. Among authors: van der bruggen p. Front Immunol. 2023 Dec 22;14:1308539. doi: 10.3389/fimmu.2023.1308539. eCollection 2023. Front Immunol. 2023. PMID: 38187391 Free PMC article.
Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
Lu YC, Parker LL, Lu T, Zheng Z, Toomey MA, White DE, Yao X, Li YF, Robbins PF, Feldman SA, van der Bruggen P, Klebanoff CA, Goff SL, Sherry RM, Kammula US, Yang JC, Rosenberg SA. Lu YC, et al. Among authors: van der bruggen p. J Clin Oncol. 2017 Oct 10;35(29):3322-3329. doi: 10.1200/JCO.2017.74.5463. Epub 2017 Aug 15. J Clin Oncol. 2017. PMID: 28809608 Free PMC article. Clinical Trial.
139 results